Current and historical daily PE Ratio for InVivo Therapeutics Holdings Corp (
FRA:04I
) from 2015 to Jun 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. InVivo Therapeutics stock (FRA:04I) PE ratio as of Jun 14 2024 is 0.
More Details
InVivo Therapeutics Holdings Corp (FRA:04I) PE Ratio (TTM) Chart
InVivo Therapeutics Holdings Corp (FRA:04I) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1197
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| InVivo Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-14 | At Loss | 2023-12-20 | At Loss |
| 2024-02-26 | At Loss | 2023-12-19 | At Loss |
| 2024-02-23 | At Loss | 2023-12-18 | At Loss |
| 2024-02-22 | At Loss | 2023-12-15 | At Loss |
| 2024-02-21 | At Loss | 2023-12-14 | At Loss |
| 2024-02-20 | At Loss | 2023-12-13 | At Loss |
| 2024-02-19 | At Loss | 2023-12-12 | At Loss |
| 2024-02-16 | At Loss | 2023-12-11 | At Loss |
| 2024-02-15 | At Loss | 2023-12-08 | At Loss |
| 2024-02-14 | At Loss | 2023-12-07 | At Loss |
| 2024-02-13 | At Loss | 2023-12-06 | At Loss |
| 2024-02-12 | At Loss | 2023-12-05 | At Loss |
| 2024-02-09 | At Loss | 2023-12-04 | At Loss |
| 2024-02-08 | At Loss | 2023-12-01 | At Loss |
| 2024-02-07 | At Loss | 2023-11-30 | At Loss |
| 2024-02-06 | At Loss | 2023-11-29 | At Loss |
| 2024-02-05 | At Loss | 2023-11-28 | At Loss |
| 2024-02-02 | At Loss | 2023-11-27 | At Loss |
| 2024-02-01 | At Loss | 2023-11-24 | At Loss |
| 2024-01-31 | At Loss | 2023-11-23 | At Loss |
| 2024-01-30 | At Loss | 2023-11-22 | At Loss |
| 2024-01-29 | At Loss | 2023-11-21 | At Loss |
| 2024-01-26 | At Loss | 2023-11-20 | At Loss |
| 2024-01-25 | At Loss | 2023-11-17 | At Loss |
| 2024-01-24 | At Loss | 2023-11-16 | At Loss |
| 2024-01-23 | At Loss | 2023-11-15 | At Loss |
| 2024-01-22 | At Loss | 2023-11-14 | At Loss |
| 2024-01-19 | At Loss | 2023-11-10 | At Loss |
| 2024-01-18 | At Loss | 2023-11-09 | At Loss |
| 2024-01-17 | At Loss | 2023-11-08 | At Loss |
| 2024-01-16 | At Loss | 2023-11-07 | At Loss |
| 2024-01-12 | At Loss | 2023-11-06 | At Loss |
| 2024-01-11 | At Loss | 2023-11-03 | At Loss |
| 2024-01-10 | At Loss | 2023-11-02 | At Loss |
| 2024-01-09 | At Loss | 2023-11-01 | At Loss |
| 2024-01-08 | At Loss | 2023-10-30 | At Loss |
| 2024-01-05 | At Loss | 2023-10-27 | At Loss |
| 2024-01-04 | At Loss | 2023-10-26 | At Loss |
| 2024-01-03 | At Loss | 2023-10-25 | At Loss |
| 2024-01-02 | At Loss | 2023-10-24 | At Loss |
| 2023-12-29 | At Loss | 2023-10-23 | At Loss |
| 2023-12-28 | At Loss | 2023-10-20 | At Loss |
| 2023-12-27 | At Loss | 2023-10-19 | At Loss |
| 2023-12-22 | At Loss | 2023-10-18 | At Loss |
| 2023-12-21 | At Loss | 2023-10-17 | At Loss |
InVivo Therapeutics Holdings Corp (FRA:04I) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
InVivo Therapeutics Holdings Corp
NAICS : 325411
SIC : 2836
ISIN : US46186M4078
Description
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers